235 related articles for article (PubMed ID: 34011888)
1. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Obstet Gynecol; 2021 Jun; 137(6):e100-e115. PubMed ID: 34011888
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
3. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin Summary, Number 228.
Obstet Gynecol; 2021 Jun; 137(6):1131-1133. PubMed ID: 34011880
[TBL] [Abstract][Full Text] [Related]
4. Alternatives to excisional therapy: a clinical review of our current options to conservatively manage symptomatic leiomyomas.
Ito T; Mattingly PJ; Jan AG; Biscette SM; Kim JHJ
Curr Opin Obstet Gynecol; 2018 Aug; 30(4):279-286. PubMed ID: 29975307
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
6. Role of Medical Management for Uterine Leiomyomas.
Kashani BN; Centini G; Morelli SS; Weiss G; Petraglia F
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():85-103. PubMed ID: 26796059
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
8. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
[TBL] [Abstract][Full Text] [Related]
9. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
10. Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids.
Strand T; Kives S; Leyland N; Ashkenas J; Janiszewski P; Thiel J
J Obstet Gynaecol Can; 2020 Dec; 42(12):1475-1482.e2. PubMed ID: 33046429
[TBL] [Abstract][Full Text] [Related]
11. Indications and alternatives to hysterectomy.
Solnik MJ; Munro MG
Clin Obstet Gynecol; 2014 Mar; 57(1):14-42. PubMed ID: 24488051
[TBL] [Abstract][Full Text] [Related]
12. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
13. A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids.
Van Voorhis B
JAMA; 2009 Jan; 301(1):82-93. PubMed ID: 19050179
[TBL] [Abstract][Full Text] [Related]
14. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
15. The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
Machado RB; de Souza IM; Beltrame A; Bernardes CR; Morimoto MS; Santana N
Gynecol Endocrinol; 2013 May; 29(5):492-5. PubMed ID: 23461277
[TBL] [Abstract][Full Text] [Related]
16. Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.
Vilos AG; Oraif A; Machado M; Abu-Rafea B; Vilos GA
J Obstet Gynaecol Can; 2019 Jun; 41(6):772-781. PubMed ID: 30413336
[TBL] [Abstract][Full Text] [Related]
17. Use of medical, surgical and complementary treatments among women with fibroids.
Jacoby VL; Jacoby A; Learman LA; Schembri M; Gregorich SE; Jackson R; Kuppermann M
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():220-5. PubMed ID: 25445104
[TBL] [Abstract][Full Text] [Related]
18. Bleeding associated with uterine leiomyomas. Tailor treatment to the individual patient.
Prescrire Int; 2014 May; 23(149):130-5. PubMed ID: 24926520
[TBL] [Abstract][Full Text] [Related]
19. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
20. [Malignant neoplasms of the uterus in women treated with uterine artery embolization for presumed leiomyoma--description of three cases].
Gajewska M; Panek G
Ginekol Pol; 2013 Mar; 84(3):229-33. PubMed ID: 23700853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
